BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 113698
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.113698
Table 3 Analysis of relevant risk factors, n (%)/mean ± SD

Non-complication
(n = 49)
Complication
(n = 25)
t/χ2
P value
Age (year)62.63 ± 10.1061.04 ± 9.330.6580.513
Gender
    Male27 (55.10)15 (60.0)0.1620.687
    Female22 (44.90)10 (40.0)
Tumor diameter (cm)1.95 ± 0.801.93 ± 0.830.1240.902
Previous abdominal surgery
    No34 (69.39)19 (76.0)0.3560.551
    Yes15 (30.61)6 (24.0)
Hypertension
    No31 (63.27)14 (56.0)0.3670.545
    Yes18 (36.73)11 (44.0)
Diabetes
    No43 (87.76)23 (92.0)0.3090.578
    Yes6 (12.24)2 (8.0)
Coronary heart disease
    No46 (93.88)25 (100.0)1.5950.207
    Yes3 (6.12)0
CBC (24 h postoperatively)
    Hemameba8.60 ± 3.4410.81 ± 4.51-2.3540.021
    Hemoglobin127.96 ± 18.12124.28 ± 15.650.8630.391
Blood coagulation
    PT12.53 ± 2.1212.21 ± 1.570.6850.496
    APTT26.63 ± 2.9928.66 ± 4.78-2.2440.028
Pathology
    Adenoma25 (51.02)12 (48.00)0.060.806
    Carcinoma in situ24 (48.98)13 (52.00)
Operation methods
    PD20 (40.82)17 (68.00)4.8930.027
    EP29 (59.18)8 (32.00)


Write to the Help Desk